Submission to Health Canada Consultation on Drug Shortage Regulations

Published on July 29, 2024

In response to Health Canada’s notice of intent to amend regulations addressing health product shortages in Canada, Vital outlines sustainability challenges facing pharmaceutical distributors, including declining funding and rising operational costs. While supporting elements of the proposal, the submission raises concerns about added regulatory burden and the need to address the underlying economic drivers of drug shortages.